[Successful treatment with low-dose dasatinib in a patient with chronic eosinophilic leukemia intolerant to imatinib].

[Rinshō ketsueki] The Japanese journal of clinical hematology

Volumn 52, Issue 7, 2011, Pages 546-550

  Imagawa, Jun ^a   Harada, Yuka ^b   Yoshida, Tetsumi ^b   Tarutani, Miho ^b   Kimura, Akiro ^b   Matsumoto, Kana ^b   Morita, Kunihiko ^b   Harada, Hironori ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; DASATINIB; FIP1L1 PROTEIN, HUMAN; IMATINIB; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGED; ARTICLE; BLOOD; CASE REPORT; CHRONIC DISEASE; DRUG MONITORING; DRUG TOLERANCE; GENETICS; HUMAN; HYPEREOSINOPHILIC SYNDROME; MALE; MOLECULARLY TARGETED THERAPY; REMISSION; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; DRUG MONITORING; DRUG TOLERANCE; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MOLECULAR TARGETED THERAPY; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REMISSION INDUCTION; THIAZOLES; TREATMENT OUTCOME;

EID: 80054843232     PISSN: 04851439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)